These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18496894)

  • 1. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.
    Adhoute X; Foucher J; Laharie D; Terrebonne E; Vergniol J; Castéra L; Lovato B; Chanteloup E; Merrouche W; Couzigou P; de Lédinghen V
    Gastroenterol Clin Biol; 2008 Feb; 32(2):180-7. PubMed ID: 18496894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
    de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of FibroTouch and FibroScan with the stage of primary biliary cirrhosis].
    Zhang YG; Zhao SX; Zhou GD; Li WC; Ren WG; Du HJ; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):902-906. PubMed ID: 28073410
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.
    Legros L; Bardou-Jacquet E; Latournerie M; Guillygomarc'h A; Turlin B; Le Lan C; Désille Y; Lainé F; Moirand R; Brissot P; Deugnier Y; Guyader D
    Liver Int; 2015 Jun; 35(6):1731-8. PubMed ID: 25495562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
    Castéra L; Vergniol J; Foucher J; Le Bail B; Chanteloup E; Haaser M; Darriet M; Couzigou P; De Lédinghen V
    Gastroenterology; 2005 Feb; 128(2):343-50. PubMed ID: 15685546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.
    Fernandez M; Trépo E; Degré D; Gustot T; Verset L; Demetter P; Devière J; Adler M; Moreno C
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1074-9. PubMed ID: 26011235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test.
    Calès P; Boursier J; Oberti F; Bardou D; Zarski JP; de Lédinghen V;
    J Clin Gastroenterol; 2015 Jul; 49(6):512-9. PubMed ID: 24828359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.
    Ong SY; Khoo T; Nicoll AJ; Gurrin L; Worland T; Pateria P; Ramm LE; Testro A; Anderson GJ; Skoien R; Powell LW; Ramm GA; Olynyk JK; Delatycki MB
    Sci Rep; 2021 Jul; 11(1):14654. PubMed ID: 34282177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.
    Morrison ED; Brandhagen DJ; Phatak PD; Barton JC; Krawitt EL; El-Serag HB; Gordon SC; Galan MV; Tung BY; Ioannou GN; Kowdley KV
    Ann Intern Med; 2003 Apr; 138(8):627-33. PubMed ID: 12693884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Fibroscan in predicting the presence of varices in patients with cirrhosis.
    Al-Hamoudi WK; Abdelrahman AA; Helmy A; Anil S; Khamis N; Arafah M; Alswat KA; Suwefy YM; Sanai FM; Al Faleh F; Abdo AA
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1307-12. PubMed ID: 26193054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
    Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
    Cassinotto C; Lapuyade B; Mouries A; Hiriart JB; Vergniol J; Gaye D; Castain C; Le Bail B; Chermak F; Foucher J; Laurent F; Montaudon M; De Ledinghen V
    J Hepatol; 2014 Sep; 61(3):550-7. PubMed ID: 24815876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.
    Friedrich-Rust M; Schwarz A; Ong M; Dries V; Schirmacher P; Herrmann E; Samaras P; Bojunga J; Bohle RM; Zeuzem S; Sarrazin C
    Ultraschall Med; 2009 Oct; 30(5):478-84. PubMed ID: 19813157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease].
    Kim SG; Kim YS; Jung SW; Kim HK; Jang JY; Moon JH; Kim HS; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Hepatol; 2009 Mar; 15(1):42-51. PubMed ID: 19346784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Ikegami T; Yamashita Y; Itoh S; Kuroda Y; Maehara Y
    Transplantation; 2008 Jan; 85(1):69-74. PubMed ID: 18192914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.